BridgeMD
New treatment option for ICU Acquired Weakness
Official title Effect of the "Sitting Out of Bed in an Arm-chair Position" in ICU on Functional Recovery Among Ventilated Patients
ClinicalTrials.gov ID: NCT06973746
What this study is testing
- What it's testing
- Chair positioning is one of a series of early mobilization techniques. At present, this technique, which involves moving a patient out of the resuscitation bed, can be performed passively or actively.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient \> 18 years old
- Patient on invasive mechanical ventilation for more than 24 hours
- Patient in recovery phase with a RASS score greater than "-3" for more than 12 hours
- Stay expected to last 48 hours
- Patient has never been placed in a chair during this hospitalization in intensive care.
You likely can't join if
- Patient with an absolute and non-resolving contraindication to chair positioning
- Fracture or orthopedic disorder contraindicating mobilization out of bed
- Obesity with body mass index greater than 45 kg/cm2
- Sacral eschar stage greater than 2
- Patient using a wheelchair for mobility (i.e. paraplegic patient or patient with progressive neurological pathology).
- Patient treated with veno-venous or veno-arterial ECMO at the time of screening.
See the full eligibility criteria
- Patient \> 18 years old
- Patient on invasive mechanical ventilation for more than 24 hours
- Patient in recovery phase with a RASS score greater than "-3" for more than 12 hours
- Stay expected to last 48 hours
- Patient has never been placed in a chair during this hospitalization in intensive care.
- Fragility score \< 6, during the month preceding admission to intensive care
- Patient (or support person/relative if patient is unable to participate) who has agreed to take part in the study.
- Patient with an absolute and non-resolving contraindication to chair positioning
- Fracture or orthopedic disorder contraindicating mobilization out of bed
- Obesity with body mass index greater than 45 kg/cm2
- Sacral eschar stage greater than 2
- Patient using a wheelchair for mobility (i.e. paraplegic patient or patient with progressive neurological pathology).
- Patient treated with veno-venous or veno-arterial ECMO at the time of screening.
- Moribund patient
- Encephalic death
- Acute polyradiculoneuritis (Guillain-Barré syndrome)
- Myasthenia
- Patient treated by continuous hemodialysis or hemofiltration for more than 72 hours following the onset of awakening.
- Complete transmetatarsal or higher amputation of one or both lower limbs.
- Protected person (under guardianship or curatorship)
- Person under court protection
- Person not affiliated to a social security scheme
- Pregnant or breast-feeding woman
- Patient already included in the study
- Patient taking part in an treatment clinical study, the aim of which is to show an improvement in functional level on discharge from the intensive care unit or which focuses on the theme of early rehabilitation in the...
The study team makes the final eligibility decision.
Where it's taking place
- Orléans, Centre-Val de Loire, France
- Belfort, France
- Clermont-Ferrand, France
- Dax, France
- Dijon, France
- Le Coudray, France
- Le Mans, France
- Mont-de-Marsan, France
- Saint-Lô, France
- Suresnes, France
- Tours, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orléans, Centre-Val de Loire, France; Belfort, France; Clermont-Ferrand, France; Dax, France; Dijon, France; Le Coudray, France and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.